TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Return to Function (Shoulder)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: clinical success rate of pulpotomy procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographical success rate of pulpotomy procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central-line associated bloodstream infections (CLABSI) rates
Endpoint domain: Adverse events/effects
Primary endpoint: Sonographic Cardiac index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: First second of forced expiration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Serum sclerostin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal urine flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Elevated serum tobramycin trough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Creatinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood flow/min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Radiological outcome using modified TICI grade (mTICI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical outcome using modified Rankin Scale (mRS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cardiovascular health score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients able to move over 5 metres
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in trough forced expiratory volume in 1 second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in Cardiorespiratory fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinico-radiological evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Feasibility of achieving rapid optimal medical therapy in intervention arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of patient-reported outcome measure (PROM) collection & participant retention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge, Attitude and Practice regarding Iron, Folic Acid and Multivitamins
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concentration of FBG, PBG and HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of MBG, TIR, TAR, TBR, MAGE, MBG and LAGE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of bleeding from site
Endpoint domain: Adverse events/effects
Primary endpoint: Evidence of skin reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Acute myocardial infarction incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oxygenation index changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased probability of detecting AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients controlled
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial nerve function assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of psychoactive drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dichotic Listening Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Impact of colesevelam on plasma & stool bile acid concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Shear Strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in care type of BHRe in ICU
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety of Fosaprepitant Dimeglumine
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of Fosaprepitant Dimeglumine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial wrinkle scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of systemic treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of systemic treatments
Endpoint domain: Adverse events/effects
Primary endpoint: daily steps (paces)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Human Activity Profile (HAP)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: POGO (Percentage of Glottic Opening) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe coagulopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cytokine response in ECMO patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cytokine response in patients with septic shock
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Choriocapillary vessel density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Day 28 PCR corrected cure rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Day 42 PCR corrected cure rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients diagnosed with pulmonary infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pain last week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of emergency episodes and outpatient visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Performance of nPOC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability assessed by dose-limiting toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Time to complete healing of wound site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proteomics and metabolomics changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incident dyskalemia after 2 months of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of Symptom score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of Medication score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of Combination symptom-medication score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to improvement in best corrected visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average adipose cell cluster size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Absence of the most bothersome symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients that are responders based on abdominal pain intensity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Paternal-Infant Attachment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cortical gray matter volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortical gray matter thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right ventricle systolic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Expired fractions of nitric oxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 3-OHB CSF/blood ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of HCV, HBV, HIV testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in patients' CHF specific health-related quality of life immediately post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in patients' CHF specific health-related quality of life at 3-month post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in patients' generic health-related quality of life immediately post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in patients' generic health-related quality of life at three-month post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in caregivers' health-related quality of life immediately post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: obesity severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fatty liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in serological response to Gardasil-9
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of patients initiating therapy with a SGLT-2 inhibitor
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Sagittal knee joint kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Echocardiogram Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean change in Tampa scale for kinesiophobia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Wechsler Preschool and Primary Scale of Intelligence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test of Nonverbal Intelligence-Fourth Edition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PedsQL TM
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Kinesthetic and Visual Imagery Questionnaire (KVIQ)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mental Stopwatch
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Jebson-Taylor Hand Function Test (JTHFT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Manual Ability Measure-36 (MAM-36)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Disagreement score on artificial hydration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: First puncture success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom assessment using MDASI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognitive performance: Go NoGo task: attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cognitive performance: Go NoGo task: response inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Per capita household fish consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Frequency of fish consumed at household level
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to reach 2L NC or room air
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Average Pain on First postoperative day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of local anesthetic administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cumulative 24 hour total opioid consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Numeric Rating Scale (NRS) Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline oxygen (VO2) at VT1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Referable Diabetic Retinopathy screening sensitivity/specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Influenza Vaccination uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: change in severity of dryness as most bothersome symptom of GSM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete resolution of the treatment wart
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time needed to intubate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of patients with benign disease who underwent invasive diagnostic procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to diagnosis (in days) for patients with cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete remission with incomplete hematologic recovery (CRi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum concentration of inflammatory cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Absolute number of lymphocyte subsets in the peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: OMNI Vocal Effort Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of Voice Interruptions (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in accelerometer-measured moderate-to-vigorous intensity physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported moderate-to-vigorous intensity physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to intervention protocol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in baseline positive affect at 4 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in baseline negative affect at 4 weeks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Complete closure of tympanic membrane perforation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Minutes of weekly moderate to vigorous physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of acute >grade 2 radiation dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Change in balance stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appropriate Emergency Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COVID-19 symptoms severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RBC transfusion independence for ≥ 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine protein creatinine ratio ≤ 2 mg/mg maintained over ≥ 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain assessment using LANSS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain assessment using DN4 questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 3-year progression-free survival ratio
Endpoint domain: Mortality/survival
Primary endpoint: Mycobacterial load in induced sputum samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average knowledge assessment scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Dyspigmentation Spots
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in UV Spots
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Brown Spots
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Physician's Global Assessment Scores (PGAS)- Right Face
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician's Global Assessment Scores (PGAS)- Left Face
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician's Global Assessment Score (PGAS)- Overall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Borderline Symptom List 23 (BSL-23)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Kidney Disease Quality of Life Form (KDQOL-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cumulative incidence of any cancer
Endpoint domain: Mortality/survival
Primary endpoint: Gastrointestinal Tolerability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Positive CMV Immunoglobulin (IgG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patients' satisfaction with their sexual lives
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dyspnoea (Medical Research Council Dyspnoea Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Flow Meter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean change in the disease severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalization & Survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Number of detection of neoplastic colon polyp
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Glu and GABA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Implant survival / success rate
Endpoint domain: Mortality/survival
Primary endpoint: Patient postoperative experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Thrombin generation (TG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rey Auditory Verbal Learning (RAVLT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Digit span Forward and Backward tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Stroop task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Digit Symbol-Substitution Task (DSST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: comfort of the device
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Handling of the device
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Test-retest reliability of the VR-based 9-hole peg test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interproximal Mean Turesky Plaque Index (TPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Interproximal Mean Modified Gingival Index (MGI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Severe perinatal morbidity and mortality
Endpoint domain: Mortality/survival
Primary endpoint: maximal tolerance dose (MTD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of delayed gastric emptying (ISGPS criteria)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of delayed gastric emptying (MAGS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Agreement between capillary and venous blood in the measurement of White Blood Cells and Absolute Neutrophil Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Depth of Anesthesia Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of BPPV diagnostics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral Palsy Quality of Life (CPQOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 20-meter Shuttle Run Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standing Long Jump Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90 Degree Push Up Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Warwick Edinburgh Mental Wellbeing Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: longitudinal trends in blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Analgesic effect of nerve block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic changes in plasma levels of sTREM-1 and sTREM-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes